Cell-based therapies are being developed for various neurodegenerative diseases that
affect the central nervous system (CNS). Concomitantly, the roles of individual cell types in …

Inherited retinal diseases (IRDs) can induce severe sight-threatening retinal degeneration
and impose a considerable economic burden on patients and society, making efforts to cure …

Background Ever since their discovery, induced pluripotent stem cells (iPSCs) have been
extensively differentiated into a large variety of cell types. However, a limited amount of work …

Human induced pluripotent stem cells (hiPSCs) have demonstrated great promise for a
variety of applications that include cell therapy and regenerative medicine. Production of …

Any Regenerative Medicine (RM) business requires reliably predictable cell and tissue
products. Regulatory agencies expect control and documentation. However, laboratory …

Age-related macular degeneration (AMD) is a complex disease characterized by the loss of
choroidal endothelial cells (CECs) with subsequent degeneration of the retinal pigment …

The consistent production of high-quality cells in cell therapy highlights the potential of
automated manufacturing. Humanoid robots are a useful option for transferring technology …

Autologous photoreceptor cell replacement therapy shows great promise for treating
patients with multiple forms of inherited retinal degenerative blindness. Specifically, in …

Stargardt disease (STGD1) is an inherited retinopathy affecting approximately 1: 8000
individuals. It is characterised by biallelic mutations in ABCA4 and encodes a vital protein for …